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to experience ‘an extremely stimulated imagination’ 
caused by an accidental ingestion of LSD. Three days lat-
er, on April 19, 1943, he decided to verify his results by 
intentionally ingesting LSD. This day has become known 
as ‘Bicycle Day’ as Hofmann experienced an incredible 
bicycle ride on his way home from the lab. LSD was ini-
tially hailed as a wonder drug for use in psychoanalysis, 
particularly for gaining insights into schizophrenia; but 
in the 1960s, it came to be seen by Harvard’s Timothy 
Leary and others as a pathway to spiritual enlightenment, 
 Dr. Albert Hofmann, the brilliant Swiss synthetic 
chemist, was best known for fathering the compound ly-
sergic acid diethylamide (LSD), one of the most powerful 
psychotropic substances known, on April 16, 1943. 
 Hofmann’s discovery of the effect of LSD in Basel 
came 5 years after his original synthesis of the molecule 
in 1938, LSD-25, which was set aside as he continued with 
other derivatives. Four years later, he resynthesized LSD-
25 because he felt he might have missed something the 
first time around. That day, he became the first human 
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 Fig. 1. Molecular structures of LSD and 
psilocybin, written by Dr. Albert Hof-
mann. Images courtesy of David Smith 
(www.stainblue.com). 
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and then as a major recreational drug. Thus, LSD sud-
denly became Hofmann’s ‘problem child’  [1]  and in 1966, 
the United States banned its use, followed by most other 
countries. 
 In addition to his discovery of LSD, he succeeded in 
synthesizing the active compounds used by the Mazatec 
shamans in the  Psilocybe mexicana sacred ‘magic mush-
rooms’ (psilocybin) and in morning glory seeds (lysergic 
acid monoamide and lysergic acid hydroxyethylamide) 
plus other amides that became drugs: Methergine, used 
to treat postpartum hemorrhaging, Hydergine and Dihy-
dergot used to stabilize circulation and blood pressure. 
He wrote more than 100 scientific articles and was the 
author or co-author of a number of books  [1–3] .
 Albert Hofmann, known as the ‘father of LSD’, stayed 
with Sandoz as Director of the Pharmaceutical-Chemical 
Research Laboratories Basel until his retirement in 1971. 
Then he continued to write, lecture, and play a leading 
role as an elder in the psychedelic community until his 
death at the age of 102 near Basel, Switzerland.
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